FindTrial
Sign In

Duration of Pain relief using two different intrathecal opoids (Nalbuphine vs. Fentanyl) in lower limb surgeries.

Comparative Study Between Intrathecal Nalbuphine and Fentanyl as adjuvant with Ropivacaine in lower limb surgeries: A Prospective, Randomized,Double Blind Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/05/008588
Enrollment
100
Registered
2017-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Age between 18 to 60 years, ASA I and II, both male and female patients undergoing lower limb surgery.

Interventions

Intervention1: Inj. Nelbuphine 500mcg: Inj. Nelbuphine hydro chloride 500mcg (Inj.Ruffy 10mg/ml, Dr. Reddy Laoratories Ltd.), given intrthecally along with ropivacaine. Control Intervention1: Inj. Fen

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged between 18 to 60 yrs with ASA I & II, of either sex, undergoing lower limb surgeries.

Exclusion criteria

Exclusion criteria: -Pre-existing neurological deficit/peripheral neuropathy -Coagulation disorders -Local infection at the site of block. -Pregnancy -History of allergy to amide local anesthetics -Patient refusal to participate in the study -Patient having cardio or respiratory system failure -Uncooperative patients. -Patient with h/o end organ damage

Design outcomes

Primary

MeasureTime frame
Duration of Analgesia and block characteristicsTimepoint: 12 hr.—

Secondary

MeasureTime frame
Hemodynamics and adverse eventTimepoint: 12 hr.—

Countries

India

Contacts

Public ContactDr Yashpal Singh

Institute of Medical Sciences, Banaras Hindu University, Varanasi

dryashacin1999@rediffmail.com919918424416

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026